Yahoo Finance

Norbit, trading at NOK 131, is undervalued compared to its fair value estimate of NOK 154.41. The company's earnings are projected to grow significantly at 26.1% annually, outpacing the Norwegian market's growth rate. Recent guidance targets revenues of NOK 2.2 billion to NOK 2.3 billion for 2025 with improved EBIT margins and strong demand across segments supporting this outlook. Notably, Norbit secured a substantial order worth approximately NOK 260 million in its PIR segment.

• According our earnings growth report, there's an indication that Norbit might be ready to expand.

• Get an in-depth perspective on Norbit's balance sheet by reading our health report here.

Cint Group

Overview: Cint Group AB (publ) offers software solutions for digital insights and research technology on a global scale, with a market capitalization of SEK2.42 billion.

Operations: The company's revenue is derived from two main segments: Cint Exchange, which accounts for €116.82 million, and Media Measurement, contributing €49.37 million.

Estimated Discount To Fair Value: 27.1%

Cint Group, trading at SEK 6.82, is undervalued relative to its fair value estimate of SEK 9.36. Despite a volatile share price and significant shareholder dilution over the past year, Cint's earnings are forecast to grow significantly at 94.05% annually with revenue growth expected to outpace the Swedish market average of 2.6%. The recent follow-on equity offering raised SEK 584 million which may support future profitability and strategic initiatives as outlined in recent updates.

• Our comprehensive growth report raises the possibility that Cint Group is poised for substantial financial growth.

• Unlock comprehensive insights into our analysis of Cint Group stock in this financial health report.

Turning Ideas Into Actions

• Explore the 179 names from our Undervalued European Stocks Based On Cash Flows screener here.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTPA:MEDCL OB:NORBT and OM:CINT.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com